13F Notebook
← Dashboard
Fund detail

HHLR Advisors / Hillhouse (Zhang Lei)

china, growth, hillhouse, active

Quarters 30
2021-03-31 $10.12B
Positions 91
Showing 9 of 9 rows (filtered from 108)

Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.

# Issuer Value ↓ Weight Shares Share Δ Share Δ % Prev Weight First Held Price Est. Cost Unrealized % Status
1 BRIDGEBIO PHARMA INC BBIO $330.3M 3.26% 5,362,014 +650,410 +13.80% 2.66% 2019-06-30 $62 ~$31 +98.66%
2 I MAB NBP $320.7M 3.17% 6,616,170 +5,119,630 +342.10% 0.56% 2020-09-30 $48 ~$48 +1.76%
3 KE HLDGS INC BEKE $285.6M 2.82% 5,012,100 +12,100 +0.24% 2.45% 2020-09-30 $57 ~$61 -7.04%
4 SALESFORCE COM INC CRM $240.8M 2.38% 1,136,476 +64,381 +6.01% 1.90% 2020-03-31 $212 ~$176 +20.04%
5 DOORDASH INC DASH $143.8M 1.42% 1,096,300 +237,800 +27.70% 0.97% 2020-12-31 $131 ~$141 -7.32%
6 HUAZHU GROUP LTD HTHT $31.8M 0.31% 578,902 +21,800 +3.91% 0.20% 2019-09-30 $55 ~$42 +31.08%
7 ACM RESEARCH INC ACMR $18.1M 0.18% 223,585 +9,506 +4.44% 0.14% 2020-09-30 $81 ~$72 +11.82%
8 DYNE THERAPEUTICS INC DYN $15.5M 0.15% 1,000,000 +400,000 +66.67% 0.10% 2020-09-30 $16 ~$19 -20.03%
9 FANG HLDGS LTD SFUNY $4.1M 0.04% 327,920 +297,920 +993.07% 0.00% 2020-06-30 $12 ~$13 -2.36%